| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
TTRX
Turn Therapeutics Inc
|
Jan 12, 2026 | BUY |
Strong Buy
+20.6% avg upside
2 analysts
|
$6.15
4.83% Upside
|
+42.3% |
|
REGN
Regeneron
|
Sep 15, 2023 | HOLD |
Strong Buy
+26.9% avg upside
57 analysts
|
— | +40.1% |
|
NRXS
NeurAxis, Inc.
|
Aug 23, 2023 | BUY |
Strong Buy
+5.0% avg upside
3 analysts
|
$7.50
4.98% Upside
|
-48.8% |
|
LSDIF
Lucy Scientific Discovery Inc
|
Jun 30, 2023 | BUY |
Strong Buy
+13999900.0% avg upside
1 analyst
|
$14.00
13999899.95% Upside
|
· |
|
VRTX
Vertex Pharmaceuticals
|
May 25, 2023 | HOLD |
Strong Buy
-2.6% avg upside
61 analysts
|
— | +37.4% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.